Medication library.
Names, evidence and questions for your clinician.
Medication references
- Anastrozole
- Bremelanotide (PT-141 and Vyleesi)
- Clomiphene
- Compounded semaglutide and tirzepatide
- Dutasteride
- Elamipretide (SS-31 and Forzinity)
- Estradiol: patches, gels, vaginal and oral products
- Finasteride
- Flibanserin (Addyi)
- Foundayo (orforglipron)
- Human chorionic gonadotropin (hCG)
- Liraglutide
- Metformin
- Micronized progesterone and estradiol combinations
- Minoxidil: topical and oral
- Naltrexone and low-dose naltrexone
- Ondansetron
- Oxytocin
- Prasterone (DHEA and Intrarosa)
- Semaglutide
- Sildenafil
- Sirolimus (rapamycin)
- Spironolactone
- Tadalafil
- Tesamorelin (Egrifta)
- Testosterone
- Thyroid medicines: T4, T3 and desiccated thyroid
- Tirzepatide
- Tretinoin topical
- Vardenafil
- Vitamin B12 injections
Research references
- AOD-9604
- BPC-157
- Cagrilintide and CagriSema
- CJC-1295 and modified GRF 1-29
- Enclomiphene
- Experimental peptides: what the safety record establishes
- GHK-Cu: topical products and injections
- Glutathione
- Ibutamoren (MK-677)
- Ipamorelin
- Kisspeptin
- Mecasermin and IGF-1 LR3: different products
- MOTS-c
- NAD+
- NMN and nicotinamide riboside
- Peptide combinations and proprietary blends
- Pinealon and PE-22-28 research
- Pregnenolone
- Retatrutide
- Sermorelin
- TB-500 and thymosin beta-4
- Weight-management drug research watchlist